首页 > 市场调查报告书 > 製药

眼科药物

北美干眼产品市场预测至 2031 年 - 区域分析 - 按产品、剂型、类型和配销通路

市场调查报告书

商品编码

1666250

北美干眼产品市场预测至 2031 年 - 区域分析 - 按产品、剂型、类型和配销通路

North America Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product, Dosage Form, Type, and Distribution Channel

出版日期: 2025年01月13日 | 出版商:

The Insight Partners | 英文 104 Pages | 订单完成后即时交付

价格

简介目录图表

2023年北美干眼症产品市值为38.2536亿美元，预计2031年将达到55.8777亿美元；预计 2023 年至 2031 年的复合年增长率为 4.9%。

干眼症盛行率上升推动北美干眼症产品市场

干眼症（DED）是继屈光不正和白内障之后第三常见的眼科就诊原因。干眼症的盛行率在已开发国家尤其上升。干眼症是由多种因素引起的，会导致不适、刺激和视觉障碍。根据美国眼科学会发表的一篇文章，全球每11人就有1人患有DED，不同年龄层的盛行率为5%至50%。根据爱尔康 2022 年发布的新闻稿，该疾病影响全球约 7.19 亿人，其中美国约 3,800 万人。

糖尿病视网膜病变对视网膜造成的逐渐损害进一步导致了干眼症。根据美国眼科学会发表的一篇文章，预计到 2030 年，全球将有约 1.91 亿人患有糖尿病视网膜病变。

北美干眼产品市场概览

北美干眼产品市场分为美国、加拿大和墨西哥。该地区市场的成长归因于人们对干眼症 (DED) 认识的不断提高、老龄化人口的增长、技术进步以及眼部疾病病例的增加。此外，由于新药频繁推出，各种药物易于取得，是推动该地区干眼症产品市场成长的关键因素之一。

DED 是美国常见但未被充分诊断的疾病，人口年龄的增长可能与疾病的盛行率激增有关。根据美国疾病管制与预防中心 (CDC) 的数据，白内障、黄斑部病变、糖尿病视网膜病变和青光眼等与年龄相关的眼部疾病是美国失明和视力受损的主要原因。其他常见的眼部疾病包括弱视和斜视。预计到2030年，美国将有多达279万名男性患有干眼症。 2021年1月，Kala Pharmaceuticals Inc.推出EYSUVIS 0.25%（氯替泼诺依碳酸酯眼用混悬液），用于短期（最长两週）治疗干眼症症状。 EYSUVIS 目前已在美国各地的国家和地区药品配送中心推出。

北美干眼产品市场收入及预测（2031 年）（百万美元）

北美干眼产品市场细分

北美干眼产品市场分为产品、剂型、类型、配销通路和国家。

根据产品，北美干眼产品市场分为人工泪液、抗发炎药、泪点塞、促泌剂、口服欧米茄补充剂等。 2023 年，人工泪液占据了北美干眼产品市场的最大份额。此外，泪点塞部分又细分为可溶解和可拆卸。

就剂型而言，北美干眼产品市场分为眼药水、凝胶、胶囊及锭剂等。 2023 年，眼药水占据了北美干眼产品市场最大的份额。

根据类型，北美干眼产品市场分为非处方药和处方药。 2023 年，OTC 部门占据了北美干眼产品市场的较大份额。

根据配销通路，北美干眼产品市场分为零售药局、医院药局和网路药局。 2023 年，零售药局部门占据了北美干眼产品市场最大的份额。

依国家划分，北美干眼产品市场分为美国、加拿大和墨西哥。 2023 年，美国占据北美干眼症产品市场的主导份额。

参天製药株式会社、强生公司、OASIS Medical、URSAPHARM Arzneimittel GmbH、乐敦製药有限公司、OCuSOFT Inc、博士伦医疗公司、艾伯维公司、Prestige Consumer Healthcare Inc、Farmigea SpA 和爱尔康公司。是北美干眼产品市场的一些领先公司。

Dry eye disease (DED) ranks third among the most common reasons for visits to an ophthalmology clinic after refractive errors and cataracts, respectively. The prevalence of dry eye is particularly rising in developed nations. Dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. According to an article published by the American Academy of Ophthalmology, DED affects approximately 1 in 11 people worldwide, with prevalence ranging from 5% to 50% at various ages. According to a press release by Alcon in 2022, the disease affects ~719 million people globally and ~38 million people in the US.

Progressive damage caused to the retina due to diabetic retinopathy further results in DED. According to an article published by the American Academy of Ophthalmology, ~191.0 million people globally are estimated to suffer from diabetic retinopathy by 2030. As per the Centers for Disease Control and Prevention (CDC), approximately 9.6 million people (across all ages) in the US were living with diabetic retinopathy in 2021. Thus, the increasing incidence of diabetic retinopathy is driving the growth of the dry eye products market.

North America Dry Eye Products Market Overview

The North America dry eye products market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the increasing awareness of dry eyes disease (DED), growing aging population, technological advancements, and rising eye disease cases. Moreover, an easy availability of various drugs due to frequent launches of new drugs is one of the key factors propelling the dry eye products market growth in the region.

DED is a common but underdiagnosed condition in the US, and an increase in the population age can be associated with the surging prevalence of this disease. According to the Centers for Disease Control and Prevention (CDC), age-related eye diseases such as cataract, macular degeneration, diabetic retinopathy, and glaucoma are the primary causes of blindness and impaired vision in the US. Other common eye disorders include amblyopia and strabismus. Dry eye disease is expected to affect as many as 2.79 million US men by 2030. Thus, with the rising incidence of dry eye disease, the demand for therapeutic products is on the rise in the country. In January 2021, Kala Pharmaceuticals Inc. launched EYSUVIS 0.25% (loteprednol etabonate ophthalmic suspension) for the short-term (up to two weeks) treatment of dry eye disease symptoms. EYSUVIS is now available in national and regional pharmaceutical distribution centers across the US.

North America Dry Eye Products Market Revenue and Forecast to 2031 (US$ Million)

North America Dry Eye Products Market Segmentation

The North America dry eye products market is categorized into product, dosage form, type, distribution channel, and country.

Based on product, the North America dry eye products market is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest North America dry eye products market share in 2023. Furthermore, the anti-inflammatory drugs segment is subcategorized into cyclosporine, corticosteroid, and others. Additionally, the punctal plugs segment is subsegmented into dissolvable and removable.

In terms of dosage form, the North America dry eye products market is segmented into eye drops, gel, capsules and tablets, and others. The eye drops segment held the largest North America dry eye products market share in 2023.

By type, the North America dry eye products market is bifurcated into OTC and prescription. The OTC segment held a larger North America dry eye products market share in 2023.

Based on distribution channel, the North America dry eye products market is categorized into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment held the largest North America dry eye products market share in 2023.

By country, the North America dry eye products market is segmented into the US, Canada, and Mexico. The US dominated the North America dry eye products market share in 2023.

Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA, and Alcon AG. are some of the leading companies operating in the North America dry eye products market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Dry Eye Products Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Prevalence of Dry Eye
- 4.1.2 Upsurge in Geriatric Population
4.2 Market Restraints
- 4.2.1 Side Effects of Eye Drops and Product Recalls
4.3 Market Opportunities
- 4.3.1 Increasing Initiatives for Eye Care Awareness
4.4 Future Trends
- 4.4.1 Ongoing Research and Growing Pipeline for Dry Eye Products
4.5 Impact of Drivers and Restraints:

5. Dry Eye Products Market - North America Analysis

5.1 North America Dry Eye Products Market Revenue (US$ Million), 2021-2031

6. North America Dry Eye Products Market Analysis - by Product

6.1 Overview
6.2 Artificial Tears
- 6.2.1 Overview
- 6.2.2 Artificial Tears: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Anti-Inflammatory Drugs
- 6.3.1 Overview
- 6.3.2 Anti-Inflammatory Drugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  - 6.3.2.1 North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
6.4 Punctal Plugs
- 6.4.1 Overview
- 6.4.2 Punctal Plugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  - 6.4.2.1 North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
6.5 Secretagogues
- 6.5.1 Overview
- 6.5.2 Secretagogues: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.6 Oral Omega Supplements
- 6.6.1 Overview
- 6.6.2 Oral Omega Supplements: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Dry Eye Products Market Analysis - by Dosage Form

7.1 Overview
7.2 Eye Drops
- 7.2.1 Overview
- 7.2.2 Eye Drops: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Gels
- 7.3.1 Overview
- 7.3.2 Gels: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Capsules and Tablets
- 7.4.1 Overview
- 7.4.2 Capsules and Tablets: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Dry Eye Products Market Analysis - by Type

8.1 Overview
8.2 OTC
- 8.2.1 Overview
- 8.2.2 OTC: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Prescription
- 8.3.1 Overview
- 8.3.2 Prescription: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Dry Eye Products Market Analysis - by Distribution Channel

9.1 Overview
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Hospital Pharmacies
- 9.3.1 Overview
- 9.3.2 Hospital Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Online Pharmacies
- 9.4.1 Overview
- 9.4.2 Online Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Dry Eye Products Market - Country Analysis

10.1 North America: Dry Eye Products Market
- 10.1.1 North America: Dry Eye Products Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.1.1 United States: Dry Eye Products Market Breakdown, by Product
    - 10.1.1.1.1.1 United States: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
    - 10.1.1.1.1.2 United States: Dry Eye Products Market Breakdown, by Punctal Plugs
    - 10.1.1.1.2 United States: Dry Eye Products Market Breakdown, by Dosage Form
    - 10.1.1.1.3 United States: Dry Eye Products Market Breakdown, by Type
    - 10.1.1.1.4 United States: Dry Eye Products Market Breakdown, by Distribution Channel
  - 10.1.1.2 Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.2.3 Canada: Dry Eye Products Market Breakdown, by Product
    - 10.1.1.2.3.1 Canada: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
    - 10.1.1.2.3.2 Canada: Dry Eye Products Market Breakdown, by Punctal Plugs
    - 10.1.1.2.4 Canada: Dry Eye Products Market Breakdown, by Dosage Form
    - 10.1.1.2.5 Canada: Dry Eye Products Market Breakdown, by Type
    - 10.1.1.2.6 Canada: Dry Eye Products Market Breakdown, by Distribution Channel
  - 10.1.1.3 Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.3.3 Mexico: Dry Eye Products Market Breakdown, by Product
    - 10.1.1.3.3.1 Mexico: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
    - 10.1.1.3.3.2 Mexico: Dry Eye Products Market Breakdown, by Punctal Plugs
    - 10.1.1.3.4 Mexico: Dry Eye Products Market Breakdown, by Dosage Form
    - 10.1.1.3.5 Mexico: Dry Eye Products Market Breakdown, by Type
    - 10.1.1.3.6 Mexico: Dry Eye Products Market Breakdown, by Distribution Channel

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Dry Eye Products Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Santen Pharmaceutical Co Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Johnson & Johnson
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 OASIS Medical
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 URSAPHARM Arzneimittel GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Rohto Pharmaceutical Co Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 OCuSOFT Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Bausch Health Companies Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 AbbVie Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Prestige Consumer Healthcare Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Farmigea SpA
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Alcon AG
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Dry Eye Products Market Segmentation
Table 2. North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
Table 3. North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
Table 4. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 5. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
Table 6. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
Table 7. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
Table 8. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 9. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
Table 10. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 11. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
Table 12. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
Table 13. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
Table 14. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 15. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
Table 16. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
Table 18. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
Table 19. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
Table 20. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 21. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
Table 22. Recent Organic Growth Strategies in the Dry Eye Products Market
Table 23. Recent Inorganic Growth Strategies in the Dry Eye Products Market
Table 24. Glossary of Terms

List Of Figures

Figure 1. North America Dry Eye Products Market Segmentation, by Country
Figure 2. North America Dry Eye Products Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Dry Eye Products Market Revenue (US$ Million), 2021-2031
Figure 5. Dry Eye Products Market Share (%) - by Product (2023 and 2031)
Figure 6. Artificial Tears: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Anti-Inflammatory Drugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Punctal Plugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Secretagogues: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Oral Omega Supplements: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. North America Dry Eye Products Market Share (%) - by Dosage Form (2023 and 2031)
Figure 13. Eye Drops: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Gels: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Capsules and Tablets: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. North America Dry Eye Products Market Share (%) - by Type (2023 and 2031)
Figure 18. OTC: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Prescription: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Dry Eye Products Market Share (%) - by Distribution Channel (2023 and 2031)
Figure 21. Retail Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Hospital Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Online Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. North America: Dry Eye Products Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. North America: Dry Eye Products Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Growth Strategies in the Dry Eye Products Market